AzTrials
AzTrials

Acute Brain InjuryFOOBScan2NCT07548580

Physical Mobilisation to Acquired Brain Injury Patients in Intensive Care Units: a Prospective Cohort Study

An observational study of Acute Brain Injury, run by Copenhagen University Hospital, Rigshospitalet at 2 sites in Denmark.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The objective of this study is to quantify the amount of physical mobilisation provided to patients with moderate to severe acquired brain injury in Scandinavian neuro-ICs, and the association between intensity and duration of mobilisation, physiological data perceived to be related to the safety of high-level… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Acute Brain Injury
How many people
198 participants
Where
2 sitesDenmark
Study dates
25 Aug 2025to Jan 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients admitted to a neuro-ICU or to a regular ICU due to moderate to severe traumatic brain injury or stroke.

Who may be able to join

  • Adults (age ≥ 18 years)
  • Admitted to a neuro-ICU or to a regular ICU with dedicated beds for severe acquired brain injury patients in Scandinavia
  • Patients with moderate to severe traumatic brain injury (TBI) or stroke
  • Patients must be intubated and expected to require mechanically ventilation for at least 24 hours.

Who cannot join

  • Patients that are not likely to survive or for whom a decision has been made on palliative care.
  • Patients allergic to the Sens monitor patch or showing any type of allergic reactions from the patch after inclusion in the study that needs treatments or results in immediately removal of the patch.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Christian Gunge Riberholt, PhD contact

0045-38631600

christian.gunge.riberholt@regionh.dk

Denmark2 sites, 1 recruiting
  • Rigshospitalet

    Copenhagen

    Christian Gunge Riberholt, PhD, 0045-38631600, christian.gunge.riberholt@regionh.dk

    Recruiting
  • Odense Universitets Hospital

    Odense

    Active, not recruiting

Other trials in Denmark

About this study

Official title: Describing the Physical Mobilisation Provided to Patients With Acquired Brain Injury in Intensive Care Units: Protocol for a Prospective Cohort Study

The objective of this study is to quantify the amount of physical mobilisation provided to patients with moderate to severe acquired brain injury in Scandinavian neuro-ICs, and the association between intensity and duration of mobilisation, physiological data perceived to be related to the safety of high-level mobilisation, and amount of high-level mobilisation during the neuro-ICU stay.

Read the detailed description

In patients with severe acute brain injury (SABI) admitted to neurointensive care units (neuro-ICU), sedation and, consequently, immobilisation are applied to minimize intracranial complications such as increased intracranial pressure and metabolic crisis. However, complications associated to this immobilisation are of major concern. Physical inactivity has been demonstrated to have a negative impact on health in several studies and is accepted as a health threat in the general population.

For patients in neuro-ICUs with severe traumatic brain injury or acute stroke, both inactivity and high levels of inflammatory markers are associated with an increased risk of developing deep vein thrombosis. As an attempt to minimise inactivity-related complications, earlier onset of out-of-bed mobilisation in ICUs has gained increased interest, but the evidence for effect is small and inconclusive and does not address intensity.

The primary objective of this study is to quantify the amount of physical mobilisation provided to patients with moderate to severe acquired brain injury in Scandinavian neuro-ICUs, and the association between intensity and duration of mobilisation, physiological data perceived to be related to the safety of high-level mobilisation (as defined under Monitoring physical activity below), and amount of high-level mobilisation during the neuro-ICU stay. As secondary objectives, we aim to explore the association between the frequency of high-level mobilisation sessions during the neuro-ICU stay and the outcomes indicated as relevant by clinicians in Scandinavian neuro-ICUs.

Keywords
Acute brain injury, Mobilisation
Medical subject headings
Brain Injuries

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Amount of physical mobilisation

    Amount of physical mobilisation provided during stay at neuro-ICU

    Measured: From admission at the intensive care unit (ICU) until discharge from the ICU, with a maximum of 3 months.

  2. Amount of high-level mobilisation

    Amount of high-level mobilisation during stay at neuro-ICU

    Measured: From admission at the intensive care unit (ICU) until discharge from the ICU, with a maximum of 3 months.

  3. Association between intensity and duration of mobilisation

    The association between the intensity and duration of mobilisation during stay at neuro-ICU

    Measured: From admission at the intensive care unit (ICU) until discharge from the ICU, with a maximum of 3 months.

Secondary outcomes (1)
  1. Association between frequency of high-level mobilisation and outcomes indicated relevant

    Outcomes indicated relevant by clinicians in Scandinavian neuro-ICUs

    Measured: From admission at the intensive care unit (ICU) until discharge from the ICU, with a maximum of 3 months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Apr 2026
  2. Study start25 Aug 2025
  3. Primary completionJun 2026 (estimated)
  4. Study completionJan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
198 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07548580
Sponsor's protocol ID
H-24084284
Acronym
FOOBScan2
Status last verified
Apr 2026
First submitted
3 Sep 2025
Last updated
23 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Brain Injury, run by Copenhagen University Hospital, Rigshospitalet at 2 sites in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Christian Gunge Riberholt, PhD (0045-38631600, christian.gunge.riberholt@regionh.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Amount of physical mobilisation (time frame: From admission at the intensive care unit (ICU) until discharge from the ICU, with a maximum of 3 months.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in